These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3285834)

  • 21. Role of loop diuretics in chronic renal failure.
    Russo D; Minutolo R; Andreucci VE
    Cardiology; 1994; 84 Suppl 2():162-70. PubMed ID: 7954540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torasemide in the treatment of patients with cirrhosis and ascites.
    Gentilini P; Laffi G; La Villa G; Carloni V; Foschi M; Romanelli RG; Marra F
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():81-5. PubMed ID: 8435382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L; Ambroes Y; Lameire N
    Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
    TORAFIC Investigators Group
    Clin Ther; 2011 Sep; 33(9):1204-1213.e3. PubMed ID: 21906812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial responses of oedematous patients to furosemide and S1520.
    Leary WP; Asmal AC; Seedat YK; Samuel P
    S Afr Med J; 1974 Jan; 48(4):119-22. PubMed ID: 4596127
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of various diuretics on cardiac function in rats with heart failure].
    Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of torasemide and furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Thandavarayan RA; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Feb; 75(3):649-59. PubMed ID: 18001696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Update: prolonged-release torasemide].
    Acuña C
    Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
    Dupont AG; Gerlo E; Van der Niepen P; Laekeman G; Piepsz A
    Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
    Delarge J
    Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.